Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. NORDIC GROWTH MARKET
  5. Nanologica AB (publ)
  6. News
  7. Summary
    NICA   SE0005454873

NANOLOGICA AB (PUBL)

(NICA)
  Report
End-of-day quote. End-of-day quote NORDIC GROWTH MARKET - 01/18
15.7 SEK   0.00%
03:52aNANOLOGICA : Signs Credit Line with Main Owner
PU
03:52aNANOLOGICA : Changes Dates for Financial Reports
PU
2021NANOLOGICA : Stock option program in Nanologica ab fully subscribed
PU
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Nanologica Announces the Nomination Committee for the 2022 Annual General Meeting

10/29/2021 | 07:11am EST
Nanologica Announces the Nomination Committee for the 2022 Annual General Meeting

In accordance with the decision taken at the annual general meeting on May 27, 2021, the three largest shareholders as of September 30, 2021 have been contacted by the chairman of the board and been offered to appoint a member each to the nomination committee of Nanologica AB.

The three largest shareholders as of September 30, 2021 have each appointed one representative so that the nomination committee for the annual general meeting 2022 consists of the following members:

  • Carl-Johan Spak (Flerie Invest AB)
  • Lennart Francke (Swedbank Robur Medica)
  • Joakim Persson (Vega Bianca AB)

The nomination committee together represents 48.3 percent of the total number of votes in Nanologica AB as of September 30, 2021.

The nomination committee's task is to present proposals for resolutions for the annual general meeting 2022 regarding election of chairman of the meeting, number of board members to be elected by the meeting, election of the board of directors and chairman of the board, fees and other remuneration to the board of directors and its committees, election of auditors (if applicable) and remuneration to auditors, and proposal for the principles that will apply to the composition and work of the nomination committee for the next annual general meeting.

Nanologica's annual general meeting 2022 will be held in Stockholm June 2, 2022. Shareholders wishing to submit proposals to the nomination committee can contact the committee by e-mail to valberedning@nanologica.com no later than January 31, 2022.

For further information, please contact:

Gisela Sitbon, chairman of the board
Ph: +46 70 282 55 58 or e-mail: gisela@sitbon.nu

About Nanologica AB (publ)
Nanologica manufactures, develops, and sells nanoporous silica particles for applications within life science. Nanologica is world-leading in controlling the shape, size, porosity, and surface properties of silica particles, creating opportunities to develop unique products. Through the two business areas, Drug Development and Chromatography, the company strives towards increasing the accessibility for innovative treatments and medicines in healthcare, for the benefit of patients around the world. In Drug Development, Nanologica provides a unique drug delivery platform for local delivery of drugs to the lung with the aim of providing new treatment options for patients with lung diseases. In Chromatography, the company aims to make insulin available to more patients in need, by lowering the cost of manufacturing. Nanologica is headquartered in Södertälje and the company's share (NICA) is listed on Spotlight Stock Market. For further information, please visit www.nanologica.com.

2021-10-29 Nanologica Announces the Nomination Committee for the 2022 Annual General Meeting
Share this:
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Disclaimer

Nanologica AB published this content on 29 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 October 2021 11:10:03 UTC.


© Publicnow 2021
All news about NANOLOGICA AB (PUBL)
03:52aNANOLOGICA : Signs Credit Line with Main Owner
PU
03:52aNANOLOGICA : Changes Dates for Financial Reports
PU
2021NANOLOGICA : Stock option program in Nanologica ab fully subscribed
PU
2021NANOLOGICA : Recruits VP Chromatography
PU
2021NANOLOGICA : Company presentation Thursday Nov 18
PU
2021Vd Andreas Bhagwani intervjuas av Erik Penser Bank
PU
2021CEO comment third quarter 2021
PU
2021Nanologica Announces the Nomination Committee for the 2022 Annual General Meeting
PU
2021Vd Andreas Bhagwani presenterar tredje kvartalet 2021
PU
2021Nanologica Interim Report Jan – Sep 2021
PU
More news
Financials
Sales 2021 13,9 M 1,52 M 1,52 M
Net income 2021 -41,4 M -4,53 M -4,53 M
Net Debt 2021 - - -
P/E ratio 2021 -10,7x
Yield 2021 -
Capitalization 442 M 48,5 M 48,4 M
Capi. / Sales 2021 31,8x
Capi. / Sales 2022 8,11x
Nbr of Employees 20
Free-Float -
Chart NANOLOGICA AB (PUBL)
Duration : Period :
Nanologica AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 0
Last Close Price 15,70 SEK
Average target price 16,50 SEK
Spread / Average Target 5,10%
EPS Revisions
Managers and Directors
Andreas Bhagwani Chief Executive Officer
Eva Osterman Chief Financial Officer
Gisela Marie Sitbon Chairman
Adam Feiler Chief Technology Officer
Anna-Karin Renström Director-Operations & Strategies
Sector and Competitors